Companies / Blueprint Medicines Corp
Blueprint Medicines Corp
BPMCCIK 1597264
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | Coats Lonnel Director | Grant Grant or award | Common Stock | $49.99M | +4K +174.04% | 6,144 | low |
| Jun 21, 2024 | Durso-Bumpus Debra Executive | Sell Open-market sale | Common Stock | $4.20M | -40K -41.40% | 57,125 | medium |
| Aug 5, 2024 | Lee Philina Executive | Sell Open-market sale | Common Stock | $3.91M | -42K -54.69% | 34,729 | medium |
| Nov 15, 2021 | Albers Jeffrey W. CEO | Sell Open-market sale | Common Stock | $2.51M | -22K -10.03% | 196,542 | medium |
| May 31, 2024 | Hewes L. Becker Executive | Sell Open-market sale | Common Stock | $2.21M | -21K -32.61% | 43,202 | medium |
| Jun 21, 2024 | Durso-Bumpus Debra Executive | Sell Open-market sale | Common Stock | $1.97M | -19K -16.13% | 97,478 | medium |
| Sep 23, 2021 | McCain Tracey L Executive | Sell Open-market sale | Common Stock | $1.88M | -17K -32.36% | 36,195 | medium |
| May 12, 2021 | Albers Jeffrey W. CEO | Sell Open-market sale | Common Stock | $1.52M | -16K -8.54% | 175,401 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BPMC | common | 09627Y109 |